Vaxxas Announces That Merck Exercises Option to Apply Novel Immune System Activation Platform for Vaccine Candidate
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vaxxas, a biotechnology company commercializing a novel vaccination platform, today announced Merck, known…